Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.
Sherry L. et al, (2025), NPJ vaccines, 10
TomoCPT: a generalizable model for 3D particle detection and localization in cryo-electron tomograms
Shah PNM. et al, (2025), Acta Crystallographica Section D Structural Biology, 81, 63 - 76
Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines.
Sherry L. et al, (2025), Nature communications, 16
Monkeypox virus isolation from longitudinal samples in 11 hospitalised patients.
Callaby H. et al, (2024), The Lancet. Infectious diseases
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure (London, England : 1993), 32, 1594 - 1602.e6
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam
Thanh TT. et al, (2024), International Journal of Infectious Diseases, 147, 107173 - 107173
Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.
Asor R. et al, (2024), Proceedings of the National Academy of Sciences of the United States of America, 121
The effect of pH on the structure of Bluetongue virus VP5.
Zhang H. et al, (2024), The Journal of general virology, 105
The impact of exchanging the light and heavy chains on the structures of bovine ultralong antibodies
Clarke JD. et al, (2024), Acta Crystallographica Section F Structural Biology Communications, 80, 154 - 163
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels KB. et al, (2024), Nature Communications, 15
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Liu C. et al, (2024), Cell reports. Medicine
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
Michael BD. et al, (2024), Nature Communications, 15
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Liu C. et al, (2024), Nature communications, 15
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Zhou D. et al, (2024), Nature communications, 15
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Wei J. et al, (2024), Nature Communications, 15
Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023
Chau NVV. et al, (2024), Emerging Infectious Diseases, 30
From Voxels to Viruses: Using Deep Learning and Crowdsourcing to Understand a Virus Factory
Pennington A. et al, (2024), Citizen Science: Theory and Practice, 9
Integrative Approaches to Study Virus Structures.
Stuart DI. et al, (2024), Sub-cellular biochemistry, 105, 247 - 297
Delayed mucosal anti-viral responses despite robust peripheral inflammation in fatal COVID-19.
Sidhu JK. et al, (2023), The Journal of infectious diseases
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Michael BD. et al, (2023), Nature communications, 14
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
Roper KJ. et al, (2023), Scientific Reports, 13
Structural comparison of typical and atypical E2 pestivirus glycoproteins.
Aitkenhead H. et al, (2023), Structure (London, England : 1993)
COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.
Bou-Antoun S. et al, (2023), The Journal of antimicrobial chemotherapy, 78, ii37 - ii42
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.
Bešević J. et al, (2023), Journal of epidemiology and community health
Experimental phasing opportunities for macromolecular crystallography at very long wavelengths.
El Omari K. et al, (2023), Commun Chem, 6
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface.
Ni T. et al, (2023), iScience, 26
Accelerating drug target inhibitor discovery with a deep generative foundation model.
Chenthamarakshan V. et al, (2023), Science advances, 9
Broadly neutralizing antibodies against COVID-19.
Zhou D. et al, (2023), Current opinion in virology, 61
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy.
Ragonnet-Cronin M. et al, (2023), Nature communications, 14
Cryogenic electron ptychographic single particle analysis with wide bandwidth information transfer
Pei X. et al, (2023), Nature Communications, 14
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
Zhang P. et al, (2023)
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Wei J. et al, (2023), Nature Communications, 14
Characterization of the rotavirus assembly pathway in situ using cryoelectron tomography
Shah PNM. et al, (2023), Cell Host & Microbe, 31, 604 - 615.e4
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
Dijokaite-Guraliuc A. et al, (2023), Cell Reports, 42, 112271 - 112271
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.
Siggins MK. et al, (2023), Immunology, 168, 473 - 492
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Goldswain H. et al, (2023), Genome biology, 24
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region
Emmenegger M. et al, (2023), iScience, 26, 105928 - 105928
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
Huo J. et al, (2023), Cell Reports, 42, 111903 - 111903
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Liew F. et al, (2023), eBioMedicine, 87, 104402 - 104402
Publisher Correction: A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.
Bahar MW. et al, (2022), Commun Biol, 5
A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.
Bahar MW. et al, (2022), Commun Biol, 5
Switching of Receptor Binding Poses between Closely Related Enteroviruses
Zhou D. et al, (2022), Viruses, 14, 2625 - 2625
Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6.
Dijokaite-Guraliuc A. et al, (2022), Cell discovery, 8
Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum.
Huo J. et al, (2022), Cell discovery, 8
Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study.
Vink E. et al, (2022), Open forum infectious diseases, 9